XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings (Loss) Per Share | 9 Months Ended
--- | ---
Oct. 28, 2022
Earnings Per Share [Abstract] |
Earnings (Loss) Per Share | NOTE 3. EARNINGS (LOSS) PER SHARE The numerator for both basic and diluted EPS is net income (loss). The denominator for basic EPS is based upon the number of weighted average shares of Lands’ End common stock outstanding during the reporting periods. The denominator for diluted EPS is based upon the number of weighted average shares of Lands’ End common stock and common stock equivalents outstanding during the reporting periods using the treasury stock method in accordance with GAAP. Potentially dilutive securities for the diluted EPS calculations consist of non-vested equity shares of common stock and in-the-money outstanding options where the current stock price exceeds the option strike price. The following table summarizes the components of basic and diluted EPS:
|  | 13 Weeks Ended |  |  | 39 Weeks Ended |
(in thousands, except per share amounts) |  | October 28, 2022 |  |  | October 29, 2021 |  |  | October 28, 2022 |  |  | October 29, 2021 |
Net (loss) income |  | $ | (4,682 | ) |  | $ | 7,399 |  |  | $ | (9,232 | ) |  | $ | 26,259 |
Basic weighted average common shares outstanding |  |  | 33,064 |  |  |  | 32,981 |  |  |  | 33,196 |  |  |  | 32,910 |
Dilutive effect of stock awards |  |  | — |  |  |  | 717 |  |  |  | — |  |  |  | 798 |
Diluted weighted average common shares outstanding |  |  | 33,064 |  |  |  | 33,698 |  |  |  | 33,196 |  |  |  | 33,708 |
Basic (loss) earnings per share |  | $ | (0.14 | ) |  | $ | 0.22 |  |  | $ | (0.28 | ) |  | $ | 0.80 |
Diluted (loss) earnings per share |  | $ | (0.14 | ) |  | $ | 0.22 |  |  | $ | (0.28 | ) |  | $ | 0.78 |
Stock awards are considered anti-dilutive based on the application of the treasury stock method or in the event of a net loss. Anti-dilutive shares excluded from the diluted weighted average shares outstanding were 1,098,662 anti-dilutive shares in the 13 weeks ended October 28, 2022, 142 anti-dilutive shares in the 13 weeks ended October 29, 2021, 1,170,934 anti-dilutive shares in the 39 weeks ended October 28, 2022 and 77 anti-dilutive shares in the 39 weeks ended October 29, 2021.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration